https://pipelinereview.com/neurona-therapeutics-presents-positive-clinical-update-from-nrtx-1001-cell-therapy-trial-in-adults-with-drug-resistant-focal-epilepsy-at-american-academy-of-neurology-aan-2024-annual-meeting/
Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2024 Annual Meeting